Effects of Epigallcatechin-3-gallate in Novel Object Recognition of Ts65Dn Down Syndrome Mice by Minhas, Saniya et al.
Effects of Epigallcatechin-3-gallate in Novel Object Recognition of Ts65Dn Down Syndrome Mice 
Saniya Minhas1, Irushi Abeysekera1, Fatima Delgado1, Hardeep Dhillon1, Charles R. Goodlett2, Randall 
J. Roper1 
1Department of Biology, IUPUI, 2Department of Psychology, IUPUI 
Down syndrome (DS) is one of the most common genetic disorders and has an incidence of 1/700 births; 
which can lead to many impairments, both physically and mentally. All individuals with DS have 
cognitive impairments which results in learning and memory deficits. To study these deficits, we use the 
Ts65Dn mouse model that carries trisomy of approximately 50% of the genes found on human 
chromosome 21. DYRK1A, a gene found in three copies in both humans with DS and Ts65Dn mice has 
been shown to have increased expression in the brains of humans with DS. DYRK1A protein is involved 
in a number of critical pathways including CNS development. Epigallcatechin-3-gallate (EGCG), the 
main polyphenolic compound found in green tea, inhibits DYRK1A. We hypothesize that EGCG treatment 
help improve cognitive deficits in trisomic mice. After treatment, the mice were subjected to behavioral 
tasks, including the Novel Object Recognition (NOR) test. Our results indicate that there was a significant 
difference that existed due to trisomy in Ts65Dn mice; but there was no significant effect of a low dose 
EGCG treatment. Further studies are examining the effects of the NOR task after a higher dose EGCG 
treatment. 
Mentor: Randall J. Roper, Department of Biology, IUPUI, School of Science  
 
